| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0003 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |